(Abnormal Cell Therapy Solutions)
Radiofrequency ablation (RFA) is a minimally invasive procedure that uses high frequency, electrical energy and heat to destroy cancer cells.
RFA for cancerous tissue involves utilizing imaging tests to guide a thin needle (electrode) through the skin or through an incision and into the cancerous tissue. The thin needle is used as a conductor to pass high-frequency (radio), electrical energy into cancerous tissue, causing the cells surrounding the needle to heat up. Coagulation necrosis of the cancerous cells occurs within 4–6 minutes at temperatures greater than 60oC.
RFA is an alternate option when surgery isn't possible (due to risks associated with extenuating health issues), or if you have several small tumors in an organ, and works best on small cancers (smaller than 5 cm diameter), although RFA is ocassionally used to treat larger tumours. RFA can be repeated.
In some cases, side effects of RFA may include: a general feeling of unwellness for a period of time, discomfort or mild pain, hemorrhage, pneumothorax, infection (although tissue destruction also affects the incidence of infection following RFA), damage to surrounding tissue, and electrode tract seeding of tumor.
Qualight's A.C.T.S system is a non-invasive RFA system that targets cancerous cells with minimal side effects.
Current studies involve six, 10-minute sessions over a two-week period of time. Documented side effects include mild, cold-like symptoms (a general feeling of unwellness), ocassionally coupled with a slightly-raised temperature for 12-24 hours as destroyed cancerous tissue is removed by the body.
(Room Temperature Superconductor Research)
Since the discovery of the superconductivity property in mercury by Dutch physicist Heike Kamerlingh Onnes, Leiden
University, in 1911, the field of superconductivity has been constantly evolving as new engineered materials are
developed, pushing the temperature limits of superconductivity to new levels.
In 1986, Alex Müller and Georg Bednorz, IBM Research Laboratory, Rüschlikon, Switzerland, discovered
superconducting properties (Tc = 30-58 K) in a synthesized Lanthanum, Barium, Copper and Oxygen compound.
Prior to this discovery,ceramic compounds were not being considered viable candidates for
high-temperature superconductors due to their normally insulative properties.
The world record Tc of 203 K is now held by H2S (at 150 GPa pressure) - the same gas that gas that gives rotten eggs their smell. The new record holder was discovered by the Max Planck-led team, and involved by cooling it and subjecting it to high pressures by means of a diamond anvil to a pressure of 1.5 megabars (approximately half the pressure found at the Earth's core).
Qualight is engaged in the development of a true room-temperature superconductive material, capable of maintaining superconductive characteristics at temperatures above 32o F (0o C).